Toronto downtown Skyline

In brief

The Baker McKenzie Healthcare & Life Science Industry Group presented the first of a series of short webinars sharing legal industry insights and providing practical guidance in the context of today’s evolving world. On 17-18 November 2020, the session focused on a region-by-region view of the evolving compulsory licensing regimes during the COVID-19 pandemic.

The 60-minute session featured a region-by-region look at the evolving compulsory licensing regimes and how they are being shaped by the pandemic. With the mounting global pressure to secure vaccines in development and drugs showing promise as possible COVID-19 treatments, our speakers shared practical insights and updates on the compulsory licensing trends and regulations likely to affect companies across Asia Pacific; Europe, the Middle East and Africa; Latin America*; and North America.

View the recorded webinar.

Download the material.


Series link for registration.

*In cooperation with Trench Rossi Watanabe, a Brazilian law firm

Previous articleUnited Kingdom: No New Deal – but a new dawn? Consumer enforcement and the CMA
Next articleItaly: New streamlined procedure on pricing and reimbursement of generic and biosimilar drugs